Market Tracker

12/18 4:17am ET

Abbott Laboratories (NYSE:ABT)

44.26
Data as of Dec 17
 +0.86 / +1.98%
Today’s Change
35.65
Today|||52-Week Range
46.10
+15.47%
Year-to-Date

Today’s Trading

Previous close43.40
Today’s open43.47
Day’s range-- - --
Volume5,051,636
Average volume (3 months)5,121,292
Market cap$65.4B
Dividend yield2.17%
Data as of 12/17/2014

Growth & Valuation

Earnings growth (last year)-56.01%
Earnings growth (this year)+12.31%
Earnings growth (next 5 years)+10.60%
Revenue growth (last year)-45.21%
P/E ratio37.5
Price/Sales2.73
Price/Book2.67

Competitors

 Today’s
change
Today’s
% change
ACTActavis+4.38+1.71%
AGNAllergan+2.28+1.11%
LLYEli Lilly and Co+1.02+1.47%
VRXValeant Pharmaceutic...+3.08+2.25%
Data as of 12/17/2014

Financials

Next reporting dateJanuary 21, 2015
EPS forecast (this quarter)$0.69
Annual revenue (last year)$21.8B
Annual profit (last year)$2.6B
Net profit margin10.91%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive Vice President
Thomas C. Freyman
Corporate headquarters
Abbott Park, Illinois

Forecasts